Circassia Holdings Ltd

Official name: 
Circassia Holdings Limited
Registration country: 
United Kingdom
Company type: 
A specialty biopharmaceutical company focused on developing world-class immunotherapies.
Overview: 
Circassia Holdings Limited is a clinical-stage specialty biopharmaceutical company focused on developing medicines designed to control immune system responses. The Company's initial focus is on the development and commercialisation of a range of allergy therapeutics, based on its proprietary technology, which have the potential to transform current treatment.